RecruitingPhase 2NCT07446322
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
Sponsor: Oncolytics Biotech
Beverly Hills, CA · Encino, CA · Koreatown, CA · +14 more sites